Showing 12,241 - 12,260 results of 106,892 for search '(( 2 de decrease ) OR ( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.00s Refine Results
  1. 12241
  2. 12242

    MOF-Derived Hollow Heterostructure MnCo<sub>2</sub>O<sub>4</sub>@Co<sub>9</sub>S<sub>8</sub> Nanocages as a High-Performance Bifunctional Electrode for Water Electrolysis and Flexi... by Rui Yuan (615737)

    Published 2023
    “…The activity of the overall water-splitting electrolyzer did not decrease significantly even in alkaline simulated seawater, which means that it has a resistance to chlorine corrosion. …”
  3. 12243

    Image_5_Spliceostatin C, a component of a microbial bioherbicide, is a potent phytotoxin that inhibits the spliceosome.jpg by Joanna Bajsa-Hirschel (3902302)

    Published 2023
    “…In silico binding studies showed that SPC binds to a pocket between the SF3B3 and PF5A of the spliceosome.…”
  4. 12244

    Table_5_Spliceostatin C, a component of a microbial bioherbicide, is a potent phytotoxin that inhibits the spliceosome.docx by Joanna Bajsa-Hirschel (3902302)

    Published 2023
    “…In silico binding studies showed that SPC binds to a pocket between the SF3B3 and PF5A of the spliceosome.…”
  5. 12245

    Lysine 50 of Tat regulates expression of C5, CRLF2, APBA1, and BDNF genes. by Loreto Carvallo (4167607)

    Published 2017
    “…<p>THP-1Tat-Flag and THP-1Tat K50ATat-Flag cell lines (generated from independent experiments described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0179882#pone.0179882.g005" target="_blank">Fig 5</a>) were differentiated to macrophages with PMA for 24 and 48 hours. …”
  6. 12246
  7. 12247
  8. 12248
  9. 12249
  10. 12250
  11. 12251
  12. 12252
  13. 12253
  14. 12254

    NSUN2-mediated RNA m<sup>5</sup>C modification modulates uveal melanoma cell proliferation and migration by Guangying Luo (12027180)

    Published 2022
    “…<p>RNA 5-methylcytosine (m<sup>5</sup>C) is a widespread post-transcriptional modification involved in diverse biological processes through controlling RNA metabolism. …”
  15. 12255

    Rapid development of <i>de novo</i> resistance to DNA cleavage enzyme therapy. by Joshua T. Schiffer (430730)

    Published 2013
    “…<p>(a) Potent regimens with high fMOI (m*σ = 5), high enzyme – DNA binding avidity (d = 0.04), and positive binding cooperativity (h = 2) will allow for high levels of simulated resistance and predominance of resistant episomes following only 2 to 3 doses; a higher resistance rate (5% versus 1%) will promote a higher number of infected cells containing enzyme resistant episomes. …”
  16. 12256
  17. 12257
  18. 12258
  19. 12259
  20. 12260